Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$7,076,620
+$263,100 QoQ
Shares Held
27,864
-0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.91%
of 13F equity value
Holder Rank
#1,338
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pavion Blue Capital, LLC holds $13,787,434 across 7 Drug Manufacturers - General names. JNJ ranks #1 (51.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
27,864 | $7,076,620 | |
| 2 | LLY |
ELI LILLY & Co
|
1,805 | $2,164,971 | |
| 3 | ABBV |
AbbVie Inc.
|
8,426 | $2,120,318 | |
| 4 | AMGN |
Amgen Inc
|
2,846 | $1,030,593 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
14,208 | $818,664 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,345 | $296,267 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,179 | $280,001 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,076,620 | 27,864 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $6,813,520 | 27,874 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $5,837,645 | 28,208 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $5,235,519 | 28,236 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $4,312,896 | 28,235 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $5,336,399 | 32,178 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $4,682,072 | 32,375 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $5,267,112 | 32,501 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $4,750,200 | 32,500 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $5,157,784 | 32,605 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $5,123,830 | 32,690 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $5,110,780 | 32,814 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $5,402,241 | 32,638 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $5,012,700 | 32,340 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $5,719,043 | 32,375 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $5,338,604 | 32,680 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $5,802,624 | 32,689 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $5,790,281 | 32,671 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $5,375,703 | 31,424 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $5,108,083 | 31,629 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $5,229,506 | 31,744 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $5,265,280 | 32,037 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $5,120,987 | 32,539 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $4,879,542 | 32,775 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $4,538,833 | 32,275 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $4,065,161 | 31,001 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||